In the colitis model, combined LCs supplementation significantly suppressed the expression of TNF‐α, CXCL4, and caspase‐3, while enhancing occludin expression, thereby protecting against 5FU‐induced colonic apoptosis and barrier disruption. The gene discussed is PF4; the disease is colitis.